Summary & Overview
HCPCS G2113: Chronic Prednisone Therapy Status, Improved or Stable
HCPCS Level II code G2113 documents patients on long-term systemic corticosteroid therapy: specifically, those receiving more than 5 mg daily prednisone (or equivalent) for over six months who show improvement or no change in disease activity. Nationally, this code matters for tracking long-term steroid management, monitoring disease progression or stability, and ensuring accurate claims for services tied to chronic immunomodulatory care. The code is relevant across outpatient specialty clinics and primary care settings that follow patients on extended corticosteroid regimens.
Key payers referenced include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for G2113, typical service settings, and the payer landscape relevant to this code. The publication also summarizes available benchmarks where present and notes that specific coding modifiers, associated taxonomies, ICD-10 diagnoses, and related codes were not provided in the input. The content aims to clarify the code’s purpose, scope of use, and what stakeholders should expect when this code appears on claims.
Billing Code Overview
HCPCS Level II code G2113 indicates a patient who has been receiving more than 5 mg daily prednisone (or equivalent) for longer than six months, with documented improvement or no change in disease activity. This code captures a clinical status related to long-term systemic corticosteroid therapy.
-
Service type: Evaluation of chronic corticosteroid therapy status and disease activity monitoring
-
Typical site of service: Outpatient clinic or specialty practice where chronic immunosuppressive or anti-inflammatory therapy is managed
Clinical & Coding Specifications
Clinical Context
A typical patient is a 58-year-old female with long-standing polymyalgia rheumatica who has been maintained on oral prednisone 10 mg daily for 8 months with stable symptoms and no worsening of disease activity. The patient presents to a rheumatology clinic for routine follow-up to document chronic corticosteroid therapy and current disease status for billing and care coordination. The clinical workflow includes review of medication history and dosage, assessment of symptoms and physical exam, documentation of disease activity (improvement or no change), evaluation for steroid-related adverse effects, and counseling on bone health and preventive measures. The clinician confirms ongoing prednisone equivalent dose >5 mg daily for more than 6 months, documents the indication and stability of disease, and attaches the appropriate HCPCS Level II code G2113 on the visit claim. Typical sites of service include outpatient rheumatology clinics, specialty infusion or chronic disease management clinics, and hospital outpatient departments when long-term systemic corticosteroid management is being certified or monitored.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work or complexity for documentation is substantially greater than typical for the visit related to chronic steroid management (rare for G2113). |